{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pre-patellar-bursitis/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"b2ab9579-f5ec-589c-81d9-3041f5c94af1","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 5249f3d9-2a62-498e-9885-d1a759106f07 --><h2>Changes</h2><!-- end field 5249f3d9-2a62-498e-9885-d1a759106f07 -->","summary":null,"htmlStringContent":"<!-- begin item 7f2778cf-1971-479e-a9b3-46df8bf85408 --><!-- begin field 46c83593-cc78-419b-a745-5540f8b66727 --><p><strong>November to December 2016</strong> — reviewed. A literature search was conducted in November 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. Aspiration and corticosteroid injection are no longer recommended as treatments for bursitis in primary care. Minor restructuring of the topic has been undertaken.</p><!-- end field 46c83593-cc78-419b-a745-5540f8b66727 --><!-- end item 7f2778cf-1971-479e-a9b3-46df8bf85408 -->","topic":{"id":"7c029d3e-557f-550b-885f-a4fbb6ea8b1a","topicId":"54c9032c-42d1-4a7e-aa9b-60cc7c1f66b7","topicName":"Pre-patellar bursitis","slug":"pre-patellar-bursitis","lastRevised":"Last revised in December 2016","chapters":[{"id":"a3d36f54-4e47-50ed-adae-8c2966e52581","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bace3ffb-9b9e-509e-8531-d66d3c3c62b8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f4c8ac50-2d63-5270-a56e-0a3146cc2f4b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b2ab9579-f5ec-589c-81d9-3041f5c94af1","slug":"changes","fullItemName":"Changes"},{"id":"98917828-0ada-5354-9717-48e2b11fef87","slug":"update","fullItemName":"Update"}]},{"id":"aebfa517-bad1-5890-b277-d9b97452caf0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"710d52f9-ba68-5428-a898-b6c7edc2e769","slug":"goals","fullItemName":"Goals"},{"id":"0f5f5f23-030a-55f7-bb30-e90a7a6b3b4e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"dc55f8b1-83f2-529f-b685-722d05af1144","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8af4ee05-9fd0-5411-b646-4349b701edf7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"81aa996e-fa7d-541a-aacf-177f62da0eb9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"030b0978-9d73-568a-97ff-ff7eb2372e81","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"410c4858-f373-5a79-9d91-0341834ece97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"75c14afe-d269-5f9e-9fd7-b115134e3571","slug":"definition","fullItemName":"Definition"},{"id":"955fe314-c2f6-59b3-b2db-3e1696f263db","slug":"causes","fullItemName":"Causes"},{"id":"cc360743-59d8-514a-a911-cc17de6aa607","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1f7d09df-a6ff-5a6b-a2ad-e6c9c72b8755","slug":"complications","fullItemName":"Complications"},{"id":"8d7981ca-5740-5233-80da-a5b6e134534b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5a41072a-faa5-541c-9411-ffa969d2479d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b7088810-465b-5e01-81ca-9d367eed71ef","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9dc06e96-e790-5daf-8048-4f8156b87cf8","slug":"assessment","fullItemName":"Assessment"},{"id":"a8210e9d-2644-5c40-8fb6-d977678e40ff","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"a5f53d74-d84e-5651-ba73-4a6f40b49d95","slug":"aspiration-of-pre-patellar-bursitis","fullItemName":"Aspiration of pre-patellar bursitis"}]},{"id":"6ba64df6-3247-5525-8923-93745e4f9256","fullItemName":"Management","slug":"management","subChapters":[{"id":"7932f090-0d2e-5ad6-8870-388ca16b89d7","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d83f3a5e-9002-57cc-b1e5-4fc4b6456658","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"33232327-f459-5cc2-8bab-5d4f04bbb3d3","slug":"analgesia","fullItemName":"Analgesia"}]},{"id":"b3e0c735-ba47-55c9-b748-1039fc782f6d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c0171a2d-90a6-52ef-8ad8-8f6aa759b04c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3bf641c1-7809-5fa0-8a24-86be2a800942","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fa4628ed-f42b-5665-9923-827df63b1414","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"861000f2-c3de-52df-b001-757afd7049d8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"84ce47d8-9128-5472-a449-bbb9b4749a01","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"793cc2bd-ba79-52bb-a616-df2f7f376d54","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8d12b54e-612b-5890-bfdd-84eb0660aaa3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f4c8ac50-2d63-5270-a56e-0a3146cc2f4b","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"effc8132-b8a0-5559-a62d-ffae673decd9","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 8b361f9e-1525-41c6-9775-4f76dab11f9b --><h3>Previous changes</h3><!-- end field 8b361f9e-1525-41c6-9775-4f76dab11f9b -->","summary":null,"htmlStringContent":"<!-- begin item adb56190-8298-495d-9580-9c9c058c4065 --><!-- begin field 5017a4aa-d533-43e2-982a-bb90a6f971f4 --><p><strong>July 2015 </strong>—<strong> </strong>minor update. The prescribing information section for clarithromycin and erythromycin has been re-written for clarity.</p><p><strong>July 2013 </strong>— minor update. Update to the text to reflect recent advice from the MHRA regarding diclofenac.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>December 2010 </strong>— minor update. Advice on use of pressure dressings after aspiration has been clarified. Issued in December 2010.</p><p><strong>November 2010</strong>— minor update. Dose information for corticosteroid injections has now been added. Issued in November 2010.</p><p><strong>July to November 2010 </strong>— a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 5017a4aa-d533-43e2-982a-bb90a6f971f4 --><!-- end item adb56190-8298-495d-9580-9c9c058c4065 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}